These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36750670)

  • 1. Skin α-synuclein differentiates synucleinopathies.
    Lemprière S
    Nat Rev Neurol; 2023 Mar; 19(3):129. PubMed ID: 36750670
    [No Abstract]   [Full Text] [Related]  

  • 2. Structural heterogeneity of α-synuclein fibrils amplified from patient brain extracts.
    Strohäker T; Jung BC; Liou SH; Fernandez CO; Riedel D; Becker S; Halliday GM; Bennati M; Kim WS; Lee SJ; Zweckstetter M
    Nat Commun; 2019 Dec; 10(1):5535. PubMed ID: 31797870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the Track of α-Synuclein in the Body: Skin Biopsies for Diagnosing Synucleinopathies?
    Parnetti L; Bellomo G
    Neurology; 2023 Apr; 100(15):691-692. PubMed ID: 36657990
    [No Abstract]   [Full Text] [Related]  

  • 4. Detecting α-synuclein seeds in serum to diagnose synucleinopathies.
    Nat Med; 2023 Jun; 29(6):1328-1329. PubMed ID: 37286808
    [No Abstract]   [Full Text] [Related]  

  • 5. α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward.
    Bellomo G; De Luca CMG; Paoletti FP; Gaetani L; Moda F; Parnetti L
    Neurology; 2022 Aug; 99(5):195-205. PubMed ID: 35914941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies.
    Schmitz M; Candelise N; Canaslan S; Altmeppen HC; Matschke J; Glatzel M; Younas N; Zafar S; Hermann P; Zerr I
    Transl Neurodegener; 2023 Mar; 12(1):12. PubMed ID: 36915212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF Biomarkers for Early Diagnosis of Synucleinopathies: Focus on Idiopathic RBD.
    Liguori C; Paoletti FP; Placidi F; Ruffini R; Sancesario GM; Eusebi P; Mercuri NB; Parnetti L
    Curr Neurol Neurosci Rep; 2019 Jan; 19(2):3. PubMed ID: 30637520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotoxic conversion of beta-synuclein: a novel approach to generate a transgenic mouse model of synucleinopathies?
    Fujita M; Sekigawa A; Sekiyama K; Sugama S; Hashimoto M
    J Neurol; 2009 Aug; 256 Suppl 3():286-92. PubMed ID: 19711118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Update on the Critical Role of α-Synuclein in Parkinson's Disease and Other Synucleinopathies: from Tissue to Cellular and Molecular Levels.
    Serratos IN; Hernández-Pérez E; Campos C; Aschner M; Santamaría A
    Mol Neurobiol; 2022 Jan; 59(1):620-642. PubMed ID: 34750787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies.
    Brás IC; Outeiro TF
    Cells; 2021 Feb; 10(2):. PubMed ID: 33673034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies.
    Henderson MX; Trojanowski JQ; Lee VM
    Neurosci Lett; 2019 Sep; 709():134316. PubMed ID: 31170426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spreading of alpha-synuclein between different cell types.
    Ruf WP; Meirelles JL; Danzer KM
    Behav Brain Res; 2023 Jan; 436():114059. PubMed ID: 35995264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-Synuclein Proximity Ligation Assay (AS-PLA) in Brain Sections to Probe for Alpha-Synuclein Oligomers.
    Roberts RF; Bengoa-Vergniory N; Alegre-Abarrategui J
    Methods Mol Biol; 2019; 1948():69-76. PubMed ID: 30771171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy.
    Earls RH; Menees KB; Chung J; Gutekunst CA; Lee HJ; Hazim MG; Rada B; Wood LB; Lee JK
    Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1762-1771. PubMed ID: 31900358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies.
    Kawahata I; Finkelstein DI; Fukunaga K
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain region-specific susceptibility of Lewy body pathology in synucleinopathies is governed by α-synuclein conformations.
    de Boni L; Watson AH; Zaccagnini L; Wallis A; Zhelcheska K; Kim N; Sanderson J; Jiang H; Martin E; Cantlon A; Rovere M; Liu L; Sylvester M; Lashley T; Dettmer U; Jaunmuktane Z; Bartels T
    Acta Neuropathol; 2022 Apr; 143(4):453-469. PubMed ID: 35141810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies.
    Hartlage-Rübsamen M; Bluhm A; Moceri S; Machner L; Köppen J; Schenk M; Hilbrich I; Holzer M; Weidenfeller M; Richter F; Coras R; Serrano GE; Beach TG; Schilling S; von Hörsten S; Xiang W; Schulze A; Roßner S
    Acta Neuropathol; 2021 Sep; 142(3):399-421. PubMed ID: 34309760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Minimal change" multiple system atrophy with limbic-predominant α-synuclein pathology.
    Koga S; Dickson DW
    Acta Neuropathol; 2019 Jan; 137(1):167-169. PubMed ID: 30128820
    [No Abstract]   [Full Text] [Related]  

  • 19. Synucleinopathies: Where we are and where we need to go.
    Brás IC; Dominguez-Meijide A; Gerhardt E; Koss D; Lázaro DF; Santos PI; Vasili E; Xylaki M; Outeiro TF
    J Neurochem; 2020 May; 153(4):433-454. PubMed ID: 31957016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood Flow as a Route for Bidirectional Propagation of Synucleinopathy in Parkinson's Disease?
    Sgambato V
    Mov Disord; 2020 Oct; 35(10):1751. PubMed ID: 32865842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.